PPARA and melanoma: Grabacke et al. [36] previously reported that murine melanoma (B16 F10) cells and human GBM (LN-229) cells are capable of efficient synthesis and release of BHBA when treated with a PPARa agonist, although the induced ketogenesis seems to be independent of PPARa expression or activity in those cells.